Skip to content

Application of 3D Printing in Laparoscopic Surgery of Liver Tumors

Application of 3D Printing in Laparoscopic Surgery of Liver Tumors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03744624
Enrollment
85
Registered
2018-11-16
Start date
2017-04-28
Completion date
2022-12-31
Last updated
2022-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma, Liver Cancer, Liver Metastases

Keywords

3D printing, Liver cancer, Laparoscopic surgery

Brief summary

To explore the utility of personalized 3D printed liver models in planning and navigating laparoscopic resections.

Detailed description

Project goal is to evaluate utility of personalized 3D printed models in preoperative planning and performing laparoscopic liver resections. Models will be developed with unique, low-cost approach. Project will consist of three overlapping modules/stages evaluating: 1. Accuracy of 3D printed liver models compared to computed tomography and standard surface or volume rendering 2. Whether 3D printed utilized in planning surgery affects the decision making regarding the surgical plan 3. Whether 3D printed models utilized in planning and navigating laparoscopic resections affect perioperative outcomes Methodology of developing 3D models is described elsewhere. Printed models will be delivered to surgical team at least 5 days prior to the resection. Surgery will be performed in both arms according to the department's procedures and surgical oncology guidelines.

Interventions

PROCEDURELaparoscopic liver resection

Laparoscopic liver resection for oncological purposes

Use of 3D printed liver model in decision-making: preoperative planning and intraoperative guidance.

Sponsors

Jagiellonian University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 * Patient qualified to undergo liver tumor resection (either primary of metastatic; both benign and malignant lesions) * Quality of imaging (CT or MRI or PET (positron emission tomography)/CT) satisfactory to develop 3D models * Laparoscopic approach * Informed consent

Exclusion criteria

* Open approach * Technical limitations to model development * No informed consent

Design outcomes

Primary

MeasureTime frame
Number of changes in surgery planintraoperative
Blood lossintraoperative
Operative timeintraoperative

Secondary

MeasureTime frameDescription
Readmissions6 months
Complicationsintraoperative and until discharge, an average of 7 daysNumber of both total and severe (Clavien-Dindo\>=3) complications
Mortality90 days
Length of stayuntil patient discharge, an average of 7 days
Conversion rateintraoperative

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026